Man King Capsules, 2800 mg, boxes of 5 packets, OTC, Developed by: American Wanbao Pharmaceutical International Group and Hainan Wanbao Biological Engineering Co., Ltd., 27 Heping Road, Haikou, Henan Province, UPC 9 009900 0032328
Published October 3, 2012 · Recall initiated: February 23, 2012
Summary
FDA records drug Class I recall D-1699-2012, published October 3, 2012 and initiated February 23, 2012. Recalling firm: www.vitaminbestbuy.com; Status: Terminated; Reported quantity: 69 boxes; Lot: All lots. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Marketed Without an Approved ANDA/NDA: presence of sildenafil.
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- www.vitaminbestbuy.com
- Distributor
- Nationwide
- Lot
- All lots.
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAJapan Weight Loss Blue Capsules, 9 g (300 mg), 30 count box, Green algae lipotropic (fat dissolving) agent,October 3, 2012
- FDAHard Ten Days Capsule, 4500 mg, boxes of 6 packets, OTC, Developed by: American Federal International LivingOctober 3, 2012
- FDAVecuronium Bromide for Injection, For IV use only, 20 mg per vial, 10 x 10 mg Vials, lyophilized powder perOctober 3, 2012
- FDANAPROXEN TABLETS USP, 500 mg, 100-count Tablets per bottle, Rx only, Manufactured by: Glenmark Generics Ltd.,October 3, 2012
- FDASynthroid (levothyroxine sodium) Tablets USP, 112 mcg, Rx Only, 90-Count Bottle, Abbott Laboratories, NorthOctober 3, 2012
- FDALevetiracetam Tablets, USP 500 mg, 500 count bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc.October 3, 2012
Questions about this recall
Was Man King Capsules, 2800 mg, boxes of 5 packets, OTC, Developed by: American Wanbao Pharmaceutical International Group and Hainan Wanbao Biological Engineering Co., Ltd., 27 Heping Road, Haikou, Henan Province, UPC 9 009900 0032328 recalled?
Yes. FDA published recall D-1699-2012 on October 3, 2012. Reported hazard: Marketed Without an Approved ANDA/NDA: presence of sildenafil.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail